CHOP/Anthracycline Cumulative Dose Score Calculator
Cumulative dose inputs
Enter the cumulative dose received for each listed anthracycline in mg/m². Enter zero if a drug was not used.
About doxorubicin-equivalent dose
This calculator estimates cumulative doxorubicin-equivalent exposure from the three listed agents. It is a dose-conversion aid, not a validated standalone cardiotoxicity score and not a substitute for a comprehensive cardio-oncology assessment.
Conversion method
| Agent | Factor | Calculation |
|---|---|---|
| Doxorubicin | 1.0 | Dose × 1.0 |
| Daunorubicin | 0.6 | Dose × 0.6 |
| Epirubicin | 0.8 | Dose × 0.8 |
Formula: doxorubicin dose + (daunorubicin dose × 0.6) + (epirubicin dose × 0.8).
How to interpret the dose
ESC guidance uses cumulative doxorubicin-equivalent exposure as one part of risk assessment and monitoring. A cumulative dose of ≥250 mg/m² is a meaningful surveillance threshold in relevant settings; ≥250 and ≥400 mg/m² also appear in survivor risk frameworks. These bands do not determine an individual patient's risk by themselves.
References
2022 ESC Guidelines on cardio-oncology. European Heart Journal. 2022;43(41):4229–4361.
Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer. 2003;97(11):2869–2879.
The conversion ratios displayed here follow the ESC 2022 cardiovascular-toxicity dose ratio table. ESC notes that these isoequivalent ratios were derived from pediatric cancer-survivor data; applicability to every adult treatment context is not certain.
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.